Anita Elaine Weidmann

Anita Elaine Weidmann

Auto-generated profile, based on publicly available information

Anita Elaine Weidmann

Universität Innsbruck, Innsbruck, Austria

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in European Journal of Pharmacology
Verified
Journal Article
Closed access
AWAnita Elaine Weidmann
Anita Elaine Weidmann

12 March 2024 in International Journal of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
AWAnita Elaine Weidmann
Anita Elaine Weidmann
The current academic debate on the use of artificial intelligence (AI) in research and teaching has been ongoing since the launch of ChatGPT in November 2022. It mainly focuses on ethical considerations, academic integrity, authorship and the need for new legal frameworks. Time efficiencies may allow for more critical thinking, while ease of pattern recognition across large amounts of data may promote drug discovery, better clinical decision making and guideline development with resultant consequences for patient safety. AI is also prompting a re-evaluation of the nature of learning and the purpose of education worldwide. It challenges traditional pedagogies, forcing a shift from rote learning to more critical, analytical, and creative thinking skills. Despite this opportunity to re-think education concepts for pharmacy curricula several universities around the world have banned its use. This commentary summarizes the existing debate and identifies the consequences and opportunities for clinical pharmacy research and education.

1 June 2022 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Open access
DMDorothee E. Michel
Dorothee E. Michel
ATAntonella Tonna
Antonella Tonna
DDDorothee C. Dartsch
Dorothee C. Dartsch
AWAnita E. Weidmann
Anita E. Weidmann
Though medication reviews have shown positive patient outcomes, they are still not widely implemented in community pharmacies. Published reviews on their implementation often include several other pharmacy services, making them non-specific. Using the Consolidated Framework for Implementation Research (CFIR) to focus solely on the experiences of different stakeholders with the implementation of medication reviews will help to better understand relevant facilitators and barriers. To critically appraise, synthesise and present the available evidence on experiences of key stakeholders with the implementation of medication reviews and to identify barriers and facilitators to its implementation in community pharmacies. A systematic literature search was conducted in four databases for studies published in English, Spanish or German. Key search terms included: implementation, pharmac*, medication review, facilitator, barrier. Study selection, quality assessment and data extraction were performed by two independent reviewers. Findings were mapped directly against the constructs of the CFIR. Out of 924 retrieved records 24 articles from 9 countries met the inclusion criteria. Key facilitators identified included pharmacists' openness to practice change and a high degree of patient satisfaction post medication review. Attracting patients to the service was stated as challenging due to an unawareness of the scope and potential benefit of a medication review. The dominant barrier was inadequate remuneration, as it impacted all additional resourcing and ultimately the viability of the service. Further barriers included difficult professional relationships with doctors and little mandate from health authorities. Most reports were from the employed pharmacists' perspective and concerned the inner setting, other perspectives were under-reported. Results of this systematic review illustrate different stakeholders' experiences and add to the understanding of challenges in the implementation process. Nevertheless, findings also highlight how scarce reporting of external stakeholders' views is and that filling this gap can unveil hidden barriers and facilitators. PROSPERO register (CRD 42019122836).

4 January 2024 in International Journal of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
ZNZachariah Nazar
Zachariah Nazar
LNLina Naseralallah
Lina Naseralallah
DSDerek Stewart
Derek Stewart
VPVibhu PAUDYAL
Vibhu PAUDYAL
LSLaila Shafei
Laila Shafei
AWAnita Weidmann
Anita Weidmann
Background: Pharmacy practice research often focuses on the design, implementation and evaluation of pharmacy services and interventions. The use of behavioural theory in intervention research allows understanding of interventions’ mechanisms of action and are more likely to result in effective and sustained interventions. Aim: To collate, summarise and categorise the reported behavioural frameworks, models and theories used in pharmacy practice research. Method: PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science and EBSCO (CINAHL PLUS, British Education index, ERIC) were systematically searched to capture all pharmacy practice articles that had reported the use of behavioural frameworks, theories, or models since inception of the database. Results were filtered to include articles published in English in pharmacy practice journals. Full-text screening and data extraction were independently performed by two reviewers. A narrative synthesis of the data was adopted. Studies were reviewed for alignment to the UK Medical Research Council (MRC) framework to identify in which phase(s) of the research that the theory/model/framework had been employed. Results: Fifty articles met the inclusion criteria; a trend indicating an increasing frequency of behavioural theory/frameworks/models within pharmacy practice research was identified; the most frequently reported were Theory of Planned Behaviour and Theoretical Domains Framework. Few studies provided explicit and comprehensive justification for adopting a specific theory/model/framework and description of how it underpinned the research was lacking. The majority were investigations exploring determinants of behaviours, or facilitators and barriers to implementing or delivering a wide range of pharmacy services and initiatives within a variety of clinical settings (aligned to Phase 1 UK MRC framework). Conclusion: This review serves as a useful resource for future researchers to inform their investigations. Greater emphasis to adopt a systematic approach in the reporting of the use of behavioural theories/models/frameworks will benefit pharmacy practice research and will support researchers in utilizing behavioural theories/models/framework in aspects of pharmacy practice research beyond intervention development.

2 March 2012 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
AWAnita Elaine Weidmann
Anita Elaine Weidmann
SCScott Cunningham
Scott Cunningham
GGGwen Gray
Gwen Gray
DHDenise Hansford
Denise Hansford
GBGiovanna Bermano
Giovanna Bermano
DSDerek Stewart
Derek Stewart

31 March 2015 in International Journal of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
AWAnita Elaine Weidmann
Anita Elaine Weidmann
Katie MacLureKatie MacLure
Katie MacLure
SMSarah Marshall
Sarah Marshall
GGGwen Gray
Gwen Gray
DSDerek Stewart
Derek Stewart
Background Obesity has reached pandemic levels with more than 1.4 billion adults affected worldwide. While there is a need to systematically develop and evaluate community pharmacy based models of weight management, it is imperative to describe and understand the perspectives of pharmacy staff. In the UK, trained and accredited community pharmacy medicines counter assistants (MCAs) are commonly the front line staff involved in patient consultations and sale of over-the-counter medicines. Objective To explore the beliefs and experiences of pharmacists and MCAs in the North-East of Scotland on community pharmacy weight management. Setting All 135 community pharmacies in the North-East of Scotland. Method A qualitative approach of semi-structured telephone interviews with 31 pharmacists and 20 MCAs in the North-East of Scotland. The semi-structured interview schedule was developed with reference to key domains describing professional practice (i.e. awareness and knowledge, skills, practicalities, motivation, acceptance and beliefs) and contextualised with policy documents and published research on community pharmacy based weight management. Interviews were audio-recorded, transcribed and analysed thematically. Main outcome measure Pharmacists’ and MCAs’ beliefs and experiences with delivering weight management services in community pharmacy. Results There were mixed responses from pharmacists and MCAs around pharmacy based weight management services from positive views of providing the service in community pharmacy to those more reticent who would always favour patients visiting their physician. While all described similar services e.g. measurement of weight, healthy eating advice, supply of products, they acknowledged that support was often opportunistic at the request of customers, with little integration of other providers. Roles described varied from pharmacist only functions to any staff member. While pharmacists generally felt comfortable and confident, MCAs gave more diverse responses. Both Pharmacist and MCAs highlighted the need for a practice model which is systematically developed and suggested a scheme akin to the successful smoking cessation 12-week nicotine replacement therapy service already available in community pharmacies in Scotland. Conclusion Pharmacists and MCAs interviewed in this study reported their perceptions of benefits to providing community pharmacy based weight management as part of a wider public health function. They described services as opportunistic and customer driven based on ease of access. There was a notable variation in pharmacist and MCA training, reflected in their levels of comfort and confidence. There is a clear need to systematically develop and provide evidence of effectiveness and cost effectiveness for a pharmacy based practice model with key roles and functions for the full pharmacy team.